Key Details
Price
$67.00Last Dividend
$0.50Annual Revenue
$45.81 BAnnual EPS
$1.91Annual ROE
15.63%Beta
0.25Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Feb 08, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Aug 09, 2024Next split:
N/ARecent split:
July 27, 2015Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK--(BUSINESS WIRE)---- $AZN #AstraZeneca--Attorney Advertising--The law firm Bronstein, Gewirtz & Grossman, LLC, which is well-known across the country, informs investors about a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or “the Company”) (NASDAQ: AZN) and some of its executives. Class Definition This lawsuit aims to seek compensation for damages due to alleged breaches of federal securities laws on behalf of everyone who bought or acquired AstraZeneca shares.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=120648&wire=1 or reach out to Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national firm focused on shareholder rights, is reminding investors about a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ:AZN). This lawsuit claims that the company violated certain sections of the Securities Exchange Act of 1934 and related rules. Investors who bought the company's securities between February 23, 2022, and December 17, 2024, are urged to reach out to the firm before February 21, 2025.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=120711&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=120652&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=120733&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP is looking into claims for investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Investors are encouraged to reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / January 4, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=120621&wire=1 or reach out to Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national firm focused on shareholder rights, is reminding investors about a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ:AZN). This lawsuit claims that the company violated certain sections of the Securities Exchange Act of 1934 and related rules. Investors who bought AstraZeneca's securities between February 23, 2022, and December 17, 2024, are urged to reach out to the firm before February 21, 2025.
Novo Nordisk (NVO 0.15%) and AstraZeneca (AZN 0.56%) are two of the biggest names in the pharmaceutical sector. While both companies have shown solid financial results in 2024, their stock market performances tell a different story.
FAQ
- What is the primary business of AstraZeneca?
- What is the ticker symbol for AstraZeneca?
- Does AstraZeneca pay dividends?
- What sector is AstraZeneca in?
- What industry is AstraZeneca in?
- What country is AstraZeneca based in?
- When did AstraZeneca go public?
- Is AstraZeneca in the S&P 500?
- Is AstraZeneca in the NASDAQ 100?
- Is AstraZeneca in the Dow Jones?
- When was AstraZeneca's last earnings report?
- When does AstraZeneca report earnings?
- Should I buy AstraZeneca stock now?